These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15202842)

  • 21. Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin.
    Kivistö KT; Kantola T; Neuvonen PJ
    Br J Clin Pharmacol; 1998 Jul; 46(1):49-53. PubMed ID: 9690949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
    Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible colchicine rhabdomyolysis in a fluvastatin-treated patient.
    Atasoyu EM; Evrenkaya TR; Solmazgul E
    Ann Pharmacother; 2005; 39(7-8):1368-9. PubMed ID: 15956236
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoimmune hepatitis after treatment with fluvastatin.
    Castiella A; Fernandez J; Zapata E
    Liver Int; 2007 May; 27(4):592. PubMed ID: 17403199
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin.
    Baek SD; Jang SJ; Park SE; Ok TJ; Leem J; Lee HS; Park SJ; Kim TH
    J Korean Med Sci; 2011 Dec; 26(12):1634-7. PubMed ID: 22148003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.
    Sasaki S; Nakagawa M; Nakata T; Endo N; Miyao K; Kitamura K; Fukuyama M; Kitani T; Yamada C
    Cardiology; 1997; 88(2):160-5. PubMed ID: 9096917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-Induced Acute Liver Injury Within 12 Hours After Fluvastatin Therapy.
    Li L; Ma Y; Geng XB; Song YX; Tan Z; Shang XM; Zhao GY; Zhao BQ; Tian MR
    Am J Ther; 2016; 23(1):e318-20. PubMed ID: 24451297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
    Insull W; Black D; Dujovne C; Hosking JD; Hunninghake D; Keilson L; Knopp R; McKenney J; Stein E; Troendle AJ
    Arch Intern Med; 1994 Nov; 154(21):2449-55. PubMed ID: 7979841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated clinical safety experience with fluvastatin.
    Jokubaitis LA
    Am J Cardiol; 1994 May; 73(14):18D-24D. PubMed ID: 8198019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A Woman Experienced Severe Thrombocytopenia When Treated With Fluvastatin].
    Potier A; Dony A; Crapsky A; Ferry O; Piney D; Dufay E
    Therapie; 2015; 70(6):541-4. PubMed ID: 26238127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential interaction between warfarin and fluvastatin.
    Trilli LE; Kelley CL; Aspinall SL; Kroner BA
    Ann Pharmacother; 1996 Dec; 30(12):1399-402. PubMed ID: 8968451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient.
    Basic-Jukic N; Kes P; Bubic-Filipi L; Vranjican Z
    Nephrol Dial Transplant; 2010 Jun; 25(6):2036; author reply 2036-7. PubMed ID: 20332417
    [No Abstract]   [Full Text] [Related]  

  • 36. Lichenoid drug eruption induced by pravastatin; it is possible to prescribe other statins?
    Navarro-Triviño FJ; Ruiz-Villaverde R
    An Bras Dermatol; 2023; 98(1):116-117. PubMed ID: 36333170
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fluvastatin in the treatment of hyperlipoproteinemia, initial experience].
    Ceska R
    Vnitr Lek; 1996 Aug; 42(8):533-6. PubMed ID: 8967021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential warfarin-fluvastatin interaction.
    Kline SS; Harrell CC
    Ann Pharmacother; 1997 Jun; 31(6):790. PubMed ID: 9184730
    [No Abstract]   [Full Text] [Related]  

  • 39. [Statin therapy and muscle disorders].
    Abel T; Fehér J
    Orv Hetil; 2009 Feb; 150(6):261-3. PubMed ID: 19179258
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluvastatin: a review of its use in lipid disorders.
    Langtry HD; Markham A
    Drugs; 1999 Apr; 57(4):583-606. PubMed ID: 10235694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.